Hong Zheng

2PUBLICATIONS

18CO-AUTHORS

Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (2)

Sort by Publication Date:

|Sep 11, 2026

KRAS-G12C inhibition-induced enrichment of MHC-Ihigh immune-active tumor cells directs immune-effector TME development to augment therapeutic efficacy.

|Feb 09, 2023

Combination IFNβ and Membrane-Stable CD40L Maximize Tumor Dendritic Cell Activation and Lymph Node Trafficking to Elicit Systemic T-cell Immunity.

Hong Zheng, Xiaoqing Yu, Mohammed L Ibrahim

Pageof 1

Frequent Collaborators

2 joint publications

Xiaoqing Yu

2 joint publications

Mohammed L Ibrahim

2 joint publications

Dana Foresman

2 joint publications

Mengyu Xie

2 joint publications

Joseph O Johnson

2 joint publications

Theresa A Boyle

2 joint publications

Brian Ruffell

2 joint publications

Amer A Beg

1 joint publications

Bradford A Perez

1 joint publications

Scott J Antonia

Frequent Collaborators

2 joint publications

Xiaoqing Yu

2 joint publications

Mohammed L Ibrahim

2 joint publications

Dana Foresman

2 joint publications

Mengyu Xie